Benchmark study of benzamide derivatives and four novel theoretically designed (L1, L2, L3, and L4) ligands and evaluation of their biological properties by DFT approaches.
Biological applications
Density functional theory
Density of state
Frontier molecular orbitals
Proposed synthesis scheme
Journal
Journal of molecular modeling
ISSN: 0948-5023
Titre abrégé: J Mol Model
Pays: Germany
ID NLM: 9806569
Informations de publication
Date de publication:
13 Jul 2019
13 Jul 2019
Historique:
received:
03
02
2019
accepted:
02
07
2019
entrez:
15
7
2019
pubmed:
16
7
2019
medline:
21
12
2019
Statut:
epublish
Résumé
Four novel ligands, namely N-benzhydryl benzamide, N, N-diphenethyl benzamide, N, N-dihexyl benzamide, and N, N-dioctyl benzamide (L1, L2, L3, and L4, respectively), based on the benzamide unit were designed and computed for their different properties, such as absorption spectrum, dipole moment, theoretically expected biological properties, and frontier molecular orbitals, by evaluating the HOMO/LUMO energy orbitals strength with DFT approaches and comparing these properties with the R benzamide properties available in literature. All molecules have a suitable frontier molecular orbital diagram and L1 exhibits maximum absorption at 246.8 nm due to the strong electron donating effect of the diphenylmethane ligand group. Moreover, strongly extended conjugated groups caused a redshift in absorption spectra. Newly designed molecules may show strong biological activities against cancer, bacterial diseases, and harmful fungal disorders. Graphical abstract Orbital energy, electron density and frontier molecular orbitals view of four designed novel benzamide derivates.
Identifiants
pubmed: 31302811
doi: 10.1007/s00894-019-4115-3
pii: 10.1007/s00894-019-4115-3
doi:
Substances chimiques
Benzamides
0
Ligands
0
benzamide
6X80438640
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
223Références
Ann Intern Med. 1995 Jul 15;123(2):132-42
pubmed: 7778826
Eur J Med Chem. 2017 May 26;132:42-62
pubmed: 28340413
ACS Catal. 2019 Jan 4;9(1):205-210
pubmed: 31105988
J Comput Chem. 2010 Dec;31(16):2874-82
pubmed: 20928850
Eur J Med Chem. 2012 Oct;56:400-8
pubmed: 22926227
Urology. 2003 Sep;62(3):537-41
pubmed: 12946763
Angew Chem Int Ed Engl. 2011 Nov 11;50(46):10800-26
pubmed: 22038946
Chem Rev. 2010 Mar 10;110(3):1611-41
pubmed: 19928825
Org Lett. 2004 Jan 8;6(1):27-30
pubmed: 14703342
Cochrane Database Syst Rev. 2000;(2):CD000067
pubmed: 10796482
Phys Chem Chem Phys. 2008 Nov 28;10(44):6615-20
pubmed: 18989472
Arch Intern Med. 1966 Dec;118(6):528-33
pubmed: 5925440
Arch Pharm (Weinheim). 2000 Nov;333(11):365-72
pubmed: 11129978
Melanoma Res. 2005 Oct;15(5):383-91
pubmed: 16179865
Org Biomol Chem. 2018 May 9;16(18):3419-3427
pubmed: 29675524